Clinical Trials Directory

Trials / Unknown

UnknownNCT05112393

Development and Validation of Creatinine-Based Estimates of the Glomerular Filtration Rate Equation

Development and Validation of Creatinine-Based Estimates of the Glomerular Filtration Rate Equation From Chromium EDTA Imaging in the Multi-racial Malaysian Population

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University of Malaya · Academic / Other
Sex
All
Age
16 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study aim to recruit all Electronic Medical Record of patients who underwent for 51chromium ethylenediamine tetra acetic acid (51Cr-EDTA) imaging at the Nuclear Medicine Centre, University Malaya Medical Centre from September 2016 to September 2021. The data that collected will be analyzed to develop and validate a new equation to estimate Glomerular Filtration Rate that specifically for Malaysian multiracial population.

Detailed description

List of patients who underwent for 51Cr EDTA imaging at the Nuclear Medicine Centre, University Malaya Medical Centre from September 2016 to September 2021 will be obtained from relevant department. All patient's Electronic Medical Record (EMR) will be evaluated for recruitment into the study. Demographics data of the patients that will be collected include age, gender, height, weight, and ethnicity. The clinical data that will be collected include CKD aetiology, background comorbidities, and vitals sign and laboratory data includes the renal function test. The 51Cr- EDTA readings were also recorded. If there are multiple measurements of scans performed, the latest 51Cr-EDTA taken. The renal function test must be within three months of when the 51Cr-EDTA imaging was conducted. Patients will be randomized into a development and validation cohort using a random number generated in Microsoft Excel. In the development cohort, a new equation will be developed using a nonlinear regression model utilizing a generalized least squares algorithm. Internal validation will be performed in the validation cohort, by comparing the bias, precision, and accuracy of the new equations and the other established equations to the measured GFR.

Conditions

Interventions

TypeNameDescription
OTHERDevelopment of new estimating Glomerular Filtration Rate (eGFR) equationDevelopment Cohort: A new estimating Glomerular Filtration Rate(eGFR) equation will be developed by using a nonlinear regression model utilizing a generalized least squares algorithm.
OTHERValidation of new estimating Glomerular Filtration Rate (eGFR) equationValidation Cohort: Internal validation will be performed by comparing bias, precision and accuracy of the new equations and the other established equations to the measured GFR.

Timeline

Start date
2021-11-01
Primary completion
2022-08-01
Completion
2022-12-01
First posted
2021-11-08
Last updated
2021-11-08

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT05112393. Inclusion in this directory is not an endorsement.